Study guide
1.2 Erythrocyte Physiology, Metabolism & Destruction Pathways
ASCP Hematology Technologist Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Hematopoiesis & Cellular Physiology
1.1 Hematopoiesis, Bone Marrow Microenvironment & Growth Factors 1.2 Erythrocyte Physiology, Metabolism & Destruction Pathways 1.3 Leukocyte Kinetics, Morphology & Phagocytic Function 1.4 Platelet Physiology, Ultrastructure & Thrombopoiesis
2 Chapter 2: Erythrocyte Disorders & Non-Hemolytic Anemias
2.1 Iron Metabolism & Iron Deficiency Anemia 2.2 Anemia of Chronic Inflammation, Sideroblastic Anemias & Lead Toxicity 2.3 Hemoglobinopathies & Qualitative Globin Chain Defects 2.4 Alpha and Beta Thalassemias 2.5 Megaloblastic, Macrocytic & Hypoproliferative Anemias
3 Chapter 3: Hemolytic Anemias & Erythrocytosis
3.1 Intrinsic Hemolytic Anemias: Membrane & Metabolic Defects 3.2 Immune-Mediated Hemolytic Anemias & Paroxysmal Nocturnal Hemoglobinuria 3.3 Non-Immune Extrinsic Hemolytic Anemias & Microangiopathies 3.4 Polycythemia & Erythrocytosis Classification
4 Chapter 4: Benign Leukocyte Alterations, Acute Leukemias & Bone Marrow Evaluation
4.1 Quantitative Leukocyte Alterations, Toxic Change & Leukemoid Reaction 4.2 Inherited Leukocyte Anomalies, Reactive Lymphocytosis & Storage Disorders 4.3 Acute Myeloid Leukemia (AML) & Related Neoplasms 4.4 Acute Lymphoblastic Leukemia (ALL) & Precursor Lymphoid Neoplasms 4.5 Bone Marrow Examination, Differential & M:E Ratio Assessment
5 Chapter 5: Chronic Myeloid Neoplasms, MDS & Mature Lymphoid Neoplasms
5.1 Myelodysplastic Syndromes (MDS) & Overlap Syndromes 5.2 Chronic Myeloproliferative Neoplasms (CML, PV, ET, PMF) 5.3 Chronic Lymphocytic Leukemia & Indolent B-Cell Lymphomas 5.4 Aggressive Lymphomas, Hodgkin Lymphoma & Mature T-Cell Disorders 5.5 Plasma Cell Neoplasms & Monoclonal Gammopathies
6 Chapter 6: Hemostasis: Primary, Secondary & Fibrinolytic Systems
6.1 Primary Hemostasis, Platelet Receptors & Qualitative Platelet Disorders 6.2 Quantitative Platelet Disorders & Immune Thrombocytopenias 6.3 The Coagulation Cascade & Cell-Based Hemostatic Model 6.4 Fibrinolytic System, Natural Anticoagulants & Thrombophilia
7 Chapter 7: Factor Deficiencies, Coagulation Testing & Anticoagulation
7.1 Hereditary Coagulation Factor Deficiencies & von Willebrand Disease 7.2 Acquired Coagulation Factor Deficiencies, Circulating Inhibitors & DIC 7.3 Routine and Specialized Coagulation Testing & Mixing Study Interpretation 7.4 Anticoagulant Therapies, Laboratory Monitoring & Reversal Strategies 7.5 Viscoelastic Testing, Heparin Neutralization & Chromogenic Assays
8 Chapter 8: Hematology Laboratory Testing & Advanced Diagnostics
8.1 Automated Hematology Analyzers, Interference Flags & Manual Methods 8.2 Cytochemical Staining, Flow Cytometry & Molecular Diagnostics 8.3 Erythrocyte Sedimentation Rate, Hemolytic Indicators & Special Erythrocyte Studies 8.4 Cerebrospinal Fluid Analysis, Cell Counts & Cytology 8.5 Serous Effusions & Synovial Fluid Analysis
9 Chapter 9: Laboratory Operations, Quality Assessment & Safety
9.1 The Total Testing Process: Preanalytical, Analytical & Postanalytical Quality 9.2 Quality Control Statistics, Levey-Jennings Charts & Westgard Multirules 9.3 Laboratory Mathematics: Dilutions, Concentration, Molarity & Standard Curves 9.4 Method Evaluation, Diagnostic Statistics & Point-of-Care Testing 9.5 Regulatory Framework, Proficiency Testing & Competency Assessment 9.6 Laboratory Safety: Bloodborne Pathogens, Personal Protective Equipment & Chemical Hygiene 9.7 Emergency Response, Spill Management & Specimen Packaging and Transport 9.8 Hematology Instrumentation: Microscopy, Counters, Analyzers & Centrifuges
1.2 Erythrocyte Physiology, Metabolism & Destruction Pathways
Key Takeaways Explain This Topic AI
Erythropoiesis progresses through 6 morphologic stages; the polychromatophilic normoblast (rubricyte) is the final stage capable of mitotic division before nuclear extrusion at the orthochromic stage.
The red cell membrane consists of an asymmetric lipid bilayer anchored to a hexagonal spectrin-actin cytoskeleton; vertical structural defects (ankyrin, Band 3, Protein 4.2) cause Hereditary Spherocytosis, while horizontal lattice defects (spectrin dimer self-association, Protein 4.1R) cause Hereditary Elliptocytosis.
Four metabolic pathways sustain RBC viability: Embden-Meyerhof glycolysis (generates 90% of cellular ATP; PK deficiency causes hemolytic anemia), HMP shunt (10% glucose; G6PD generates NADPH/GSH to prevent Heinz body formation), Rapoport-Luebering shunt (synthesizes 2,3-BPG to modulate oxygen delivery), and Methemoglobin Reductase (NADH-cytochrome b5 maintains iron in active Fe2+ ferrous state).
Hemoglobin-oxygen binding demonstrates positive cooperativity; right-shifts (decreased affinity, increased P50, promoting tissue oxygen delivery) are driven by CADET factors: increased CO2, Acidity (low pH / Bohr effect), 2,3-DPG/BPG, Exercise, and Temperature.
Normal senescent RBC destruction is 90% extravascular in splenic macrophages (yielding unconjugated bilirubin, recycled iron, and normal haptoglobin); intravascular hemolysis releases free hemoglobin that rapidly depletes haptoglobin (<10 mg/dL), binds hemopexin, and produces hemoglobinuria, hemosiderinuria, and schistocytes.
Last updated: August 2026
Erythrocyte Physiology, Metabolism & Destruction Pathways
The mature human erythrocyte (red blood cell, RBC) is an enucleated, highly deformable biconcave disc specialized for systemic oxygen delivery and carbon dioxide elimination. Possessing a normal mean corpuscular volume (MCV) of 80 to 100 fL, a mean diameter of 6.0 to 8.0 μ m \mu\text{m} μ m , a thickness of 2.0 μ m \mu\text{m} μ m at the periphery and 1.0 μ m \mu\text{m} μ m at the central pallor, and a circulatory lifespan of approximately 120 days, the erythrocyte must undergo repeated, reversible mechanical deformation to traverse capillary beds and splenic endothelial slits as narrow as 1.0 to 2.0 μ m \mu\text{m} μ m .
Erythropoiesis Maturation Sequence & Cytology
Driven by renal erythropoietin (EPO), committed CFU-E progenitors undergo a 5- to 7-day maturation cascade through six morphologically recognizable stages. Two parallel nomenclatures are recognized by the ASCP BOC and College of American Pathologists (CAP):
Stage (CAP / Normoblastic) Stage (ASCP / Rubriblastic) Diameter & N:C Ratio Chromatin & Nucleoli Cytoplasmic Color & Organelles Mitotic Potential & Biological Milestones
Pronormoblast Rubriblast 14–20 μ m \mu\text{m} μ m ; N:C 8:1 Fine, stippled euchromatin; 1–3 pale nucleoli Deeply basophilic (rich in polyribosomes); narrow agranular rim Active mitosis; initiation of globin and protoporphyrin gene transcription.
Basophilic Normoblast Prorubricyte 12–17 μ m \mu\text{m} μ m ; N:C 6:1 Coarser, condensing chromatin ("checkerboard" or spoke pattern); nucleoli indistinct/absent Deep royal blue / violet basophilia Active mitosis; peak uptake of transferrin-bound iron and ferritin accumulation.
Polychromatophilic Normoblast Rubricyte 10–15 μ m \mu\text{m} μ m ; N:C 4:1 Dense, heavily clumped, thickened chromatin Muddy grey-pink to violet (simultaneous acidic blue RNA and alkaline pink hemoglobin) LAST STAGE CAPABLE OF MITOTIC DIVISION ; peak hemoglobin synthesis.
Orthochromic Normoblast Metarubricyte 8–12 μ m \mu\text{m} μ m ; N:C 1:1 Homogeneous, pyknotic, structureless ("ink-spot") nucleus Predominantly pink-orange (acidophilic) with slight polychromasia Non-mitotic ; late-stage nuclear polarization and active extrusion ( enucleation ).
Reticulocyte Polychromatic Erythrocyte 7–10 μ m \mu\text{m} μ m ; No nucleus Enucleated Diffuse polychromasia (grey-blue) on Wright-Giemsa; residual ribosomal RNA / reticulum visualized by supravital stains (New Methylene Blue, Brilliant Cresyl Blue) Non-mitotic; spends 2–3 days in marrow, 1–2 days in peripheral blood before final splenic maturation.
Mature Erythrocyte Erythrocyte 6–8 μ m \mu\text{m} μ m ; No nucleus Enucleated Uniform pink-salmon biconcave disc; central pallor occupies distinct central one-third of cell diameter Metabolically active via anaerobic pathways; lacks organelles, nucleus, and mitochondria; lifespan ~120 days.
Erythrocyte Membrane Architecture & Cytoskeleton
The erythrocyte membrane comprises 52% protein, 40% lipid, and 8% carbohydrate by mass, maintaining structural integrity, deformability, and selective permeability. OUTSIDE CELL (Extracellular / Plasma)
- ─────────────────────────────────────────────────────────────────────────────
- [ Glycophorin A/B/C ] [ Band 3 / AE1 ] (HCO3- / Cl- Exchanger)
- (Sialic Acid Coat) (Carries Diego Antigens)
- ═════════════════════════════════════════════════════════════════════════════
- LIPID BILAYER: Outer Leaflet (PC, SM) │ Inner Leaflet (PE, PI, PS)
- ═════════════════════════════════════════════════════════════════════════════
- │ (Vertical Linkage) │ (Horizontal Linkage)
- ▼ ▼
- [ Ankyrin (Band 2.1) + Protein 4.2 ] [ Protein 4.1R + F-Actin + Adducin ]
- │ │
- └───────────────────┬───────────────────────┘
- ▼
- [ Hexagonal Spectrin Lattice ]
- (Spectrin α-β Tetramers)
- ─────────────────────────────────────────────────────────────────────────────
- INSIDE CELL (Cytoplasm)
- 1. The Asymmetric Lipid Bilayer
Composition & Leaflet Asymmetry: The outer lipid leaflet contains uncharged phospholipids ( phosphatidylcholine [PC] and sphingomyelin [SM] ), whereas the inner (cytoplasmic) leaflet is enriched in aminophospholipids ( phosphatidylethanolamine [PE] , phosphatidylinositol [PI] , and negatively charged phosphatidylserine [PS] ).
Flippase Function & Senescence: ATP-dependent aminophospholipid translocases (flippases) maintain PS strictly in the inner leaflet. In senescent or oxidatively damaged red cells, intracellular ATP depletion inactivates flippases, causing phosphatidylserine externalization to the outer leaflet, which serves as a definitive "eat-me" signal recognized by scavenger receptors on splenic red pulp macrophages.
2. Integral Membrane Proteins
Band 3 (Anion Exchanger 1 / AE1): A 95 kDa transmembrane glycoprotein comprising ≈ 25 % \approx 25\% ≈ 25% of total membrane protein. Functions as an electroneutral bicarbonate/chloride ( H C O 3 − / C l − HCO_3^- / Cl^- H C O 3 − / C l − ) exchanger , driving the "chloride shift" essential for systemic CO 2 \text{CO}_2 CO 2 transport. Band 3 carries the Diego blood group antigens ( D i a / D i b Di^a / Di^b D i a / D i b ) and provides the primary vertical anchorage site for the underlying cytoskeleton.
Glycophorins (GPA, GPB, GPC): Sialic acid-rich transmembrane proteins providing a dense negative surface charge ( zeta potential ≈ − 15 mV \approx -15\text{ mV} ≈ − 15 mV ) that generates electrostatic repulsion, preventing red cells from aggregating in the microvasculature. Glycophorin A (GPA) expresses M and N antigens ; Glycophorin B (GPB) expresses S, s, and U antigens ; Glycophorin C (GPC) anchors the horizontal junctional cytoskeleton to the membrane.
3. Peripheral Cytoskeletal Network & Pathological Lesions
The red cell cytoskeleton is a 2D hexagonal protein lattice lining the inner membrane surface:
Spectrin: The primary cytoskeletal building block, composed of flexible α \alpha α and β \beta β chains intertwining antiparallel to form heterodimers, which self-associate head-to-head into spectrin tetramers .
Vertical Linkages (Perpendicular Anchors): Spectrin tetramers bind Ankyrin (Band 2.1) and Protein 4.2 , which link to the cytoplasmic domain of Band 3 . Mutations or deficiencies in vertical linkage proteins (ankyrin, Band 3, spectrin, or Protein 4.2) disrupt lipid bilayer attachment, leading to membrane lipid loss, surface-area-to-volume reduction, and the formation of rigid spherocytes in Hereditary Spherocytosis (HS) .
Horizontal Linkages (Lateral Lattice): The distal ends of spectrin tetramers assemble into junctional complexes with short filamentous actin (F-actin) , Protein 4.1R , Tropomyosin , and Adducin , stabilized by Glycophorin C. Mutations disrupting horizontal spectrin dimer-dimer self-association or Protein 4.1R binding compromise membrane mechanical tensile strength, causing progressive shear-induced deformation into elliptical cells in Hereditary Elliptocytosis (HE) and fragmentation in Hereditary Pyropoikilocytosis (HPP) .
The Four Core Erythrocyte Metabolic Pathways
Mature red cells lack nuclei, ribosomes, and mitochondria, relying entirely on glucose breakdown via four specialized pathways: [ GLUCOSE ]
- │
- Hexokinase / ATP ──> ADP
- ▼
- [ Glucose-6-Phosphate ]
- │
- ┌───────────────────┴───────────────────┐
- ▼ ▼
- [ EMBDEN-MEYERHOF PATHWAY ] [ HEXOSE MONOPHOSPHATE SHUNT ]
- Anaerobic Glycolysis (90% Glucose) - Aerobic Pathway (10% Glucose)
- Net Yield: 2 ATP per Glucose - Rate-Limiting Enzyme: G6PD
- Powers Na+/K+ and Ca2+ ATPases - Generates: NADPH
- Enzyme Defect: Pyruvate Kinase (PK) - NADPH maintains Reduced Glutathione (GSH)
- │ - Detoxifies H2O2 & Reactive Oxygen Species
- ▼ - Defect: G6PD Deficiency ──> Heinz Bodies
- [ 1,3-Bisphosphoglycerate ]
- │
- ┌─────────────┴─────────────┐
- ▼ ▼
- [ Glycolysis ] [ RAPOPORT-LUEBERING SHUNT ]
- Yields Pyruvate - Enzyme: BPG Mutase (BPGM)
- and Lactate - Synthesizes: 2,3-Bisphosphoglycerate (2,3-BPG)
- Yields 2 NADH - Binds deoxygenated Hb tetramer central cavity
- │ - Lowers O2 affinity ──> Promotes Tissue O2 Delivery
- ▼
- [ METHEMOGLOBIN REDUCTASE PATHWAY ]
- Enzyme: NADH-Cytochrome b5 Methemoglobin Reductase
- Uses NADH to reduce Ferric Fe3+ Methemoglobin ──> Ferrous Fe2+ Hemoglobin
- Maintains Functional Oxygen Transport Capacity
Embden-Meyerhof Pathway (Anaerobic Glycolysis): Catabolizes 90% of cellular glucose into pyruvate and lactate, generating a net 2 moles of ATP per mole of glucose. ATP fuels the Na + / K + \text{Na}^+/\text{K}^+ Na + / K + ATPase and Ca 2 + \text{Ca}^{2+} Ca 2 + ATPase pumps to maintain low intracellular Na + \text{Na}^+ Na + and Ca 2 + \text{Ca}^{2+} Ca 2 + levels, preventing osmotic swelling, cellular rigidity, and lysis. Pyruvate Kinase (PK) deficiency is the most common glycolytic enzymopathy, causing chronic non-spherocytic hemolytic anemia and echinocyte (burr cell) formation.
Hexose Monophosphate (HMP) Shunt (Pentose Phosphate Pathway): Catabolizes 10% of glucose . Glucose-6-Phosphate Dehydrogenase (G6PD) oxidizes glucose-6-phosphate, reducing NADP + \text{NADP}^+ NADP + to NADPH . NADPH is the essential cofactor for Glutathione Reductase , which regenerates reduced glutathione (GSH) from oxidized glutathione (GSSG). GSH detoxifies hydrogen peroxide ( H 2 O 2 \text{H}_2\text{O}_2 H 2 O 2 ) and free radicals via glutathione peroxidase. Under oxidative challenge (e.g., primaquine, dapsone, fava beans, infection), G6PD-deficient erythrocytes fail to generate NADPH; unchecked oxidants precipitate globin chains into insoluble Heinz bodies (visualized only with supravital stains like Crystal Violet). Splenic macrophages pit these inclusions, creating bite cells (degmacytes) and blister cells.
Rapoport-Luebering Shunt: Bypasses the ATP-generating phosphoglycerate kinase step of glycolysis. Bisphosphoglycerate Mutase/Phosphatase (BPGM) synthesizes 2,3-bisphosphoglycerate (2,3-BPG) from 1,3-BPG. 2,3-BPG binds the β \beta β -chains in the central cavity of deoxygenated hemoglobin tetramers, stabilizing the Tense (T) low-affinity conformation and facilitating oxygen offloading to hypoxic tissues.
Methemoglobin Reductase Pathway: Spontaneous oxidation of heme iron converts active ferrous iron ( Fe 2 + \text{Fe}^{2+} Fe 2 + ) into inactive ferric iron ( Fe 3 + \text{Fe}^{3+} Fe 3 + ), forming methemoglobin which cannot bind oxygen. NADH-Cytochrome b5 Methemoglobin Reductase uses NADH generated by glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in glycolysis to continuously reduce Fe 3 + \text{Fe}^{3+} Fe 3 + back to functional Fe 2 + \text{Fe}^{2+} Fe 2 + . Hereditary enzyme deficiency or toxic exposures (dapsone, benzocaine, nitrates) elevates methemoglobin ( > 1.5 % >1.5\% > 1.5% of total Hb), causing clinical cyanosis refractory to supplemental O 2 \text{O}_2 O 2 and chocolate-brown blood.
Hemoglobin Cooperativity & Oxygen Dissociation Kinetics
Adult Hemoglobin A (HbA, α 2 β 2 \alpha_2\beta_2 α 2 β 2 ) is a tetrameric allosteric protein comprising two α \alpha α -globin and two β \beta β -globin polypeptide chains, each binding a ferroprotoporphyrin IX (heme) moiety.
Allosteric Quaternary Conformations:
Tense (T) State: Deoxygenated hemoglobin; α β \alpha\beta α β dimers are constrained by salt bridges and hydrogen bonds; exhibits low affinity for oxygen.
Relaxed (R) State: Oxygenated hemoglobin; binding of oxygen pulls the Fe 2 + \text{Fe}^{2+} Fe 2 + atom into the porphyrin plane, rupturing salt bonds and rotating α β \alpha\beta α β dimers by 15 ∘ 15^\circ 1 5 ∘ ; exhibits 500-fold higher oxygen affinity.
Positive Cooperativity: Oxygen binding at one heme increases the oxygen affinity of adjacent hemes, producing a sigmoidal (S-shaped) Oxygen Dissociation Curve (ODC) ( P 50 ≈ 26.6 mmHg P_{50} \approx 26.6\text{ mmHg} P 50 ≈ 26.6 mmHg ). Under high P O 2 P\text{O}_2 P O 2 in pulmonary alveoli ( 100 mmHg 100\text{ mmHg} 100 mmHg ), hemoglobin achieves 98 % 98\% 98% saturation; at tissue P O 2 P\text{O}_2 P O 2 ( 40 mmHg 40\text{ mmHg} 40 mmHg ), saturation drops to 75 % 75\% 75% , offloading 25 % 25\% 25% of bound O 2 \text{O}_2 O 2 . % O2 Saturation
- 100 │ /───────── (Left Shift: Increased Affinity / Low P50)
- 80 │ / /─────── (Normal: P50 = 26.6 mmHg)
- 60 │ / / /───── (Right Shift: Decreased Affinity / High P50)
- 40 │ / / /
- 20 │ / / /
- 0 └───┴──┴──┴──┴──┴──┴──┴──┴──┴──┴──
- 10 20 30 40 50 60 70 80 90 100
- PO2 (mmHg)
- Factors Modulating the Oxygen Dissociation Curve
Right-Shift (Decreased Affinity / Increased P 50 P_{50} P 50 ): Promotes oxygen offloading to metabolically demanding tissues. Driven by the CADET face right factors:
C — Increased CO 2 \text{CO}_2 CO 2 (hypercapnia)
A — Acidity / Decreased pH ( Bohr Effect : H + \text{H}^+ H + binds specific histidines, stabilizing the T state)
- D — Increased 2,3-DPG / 2,3-BPG
- E — Exercise (generates heat, lactic acid, CO 2 \text{CO}_2 CO 2 )
- T — Increased Temperature (fever/hyperthermia)
Left-Shift (Increased Affinity / Decreased P 50 P_{50} P 50 ): Impairs tissue oxygen unloading, holding O 2 \text{O}_2 O 2 tightly. Driven by:
Decreased temperature (hypothermia), alkalosis (elevated pH), and depleted 2,3-BPG (e.g., in stored transfusion blood bags).
Fetal Hemoglobin (HbF, α 2 γ 2 \alpha_2\gamma_2 α 2 γ 2 ): γ \gamma γ -globin chains substitute serine for histidine 143, eliminating positive charges in the 2,3-BPG pocket. Reduced 2,3-BPG binding shifts the curve left ( P 50 ≈ 19 mmHg P_{50} \approx 19\text{ mmHg} P 50 ≈ 19 mmHg ), enabling oxygen extraction across the placenta from maternal HbA.
Carboxyhemoglobin (CO) & Methemoglobin: Lock remaining hemes in high-affinity R state, severely shifting curve left and inhibiting tissue release.
Extravascular vs. Intravascular Hemolysis Pathways
| Diagnostic Parameter | Extravascular Hemolysis (90% Physiological / Pathologic) | Intravascular Hemolysis (10% Physiological / Pathologic) |
| :--- | :--- | :--- | |
| Primary Anatomical Site | Splenic cords of Billroth (red pulp macrophages) and liver Kupffer cells | Direct lysis within the systemic intravascular vascular lumen |
| Typical Clinical Etiologies | Hereditary Spherocytosis, Warm Autoimmune Hemolytic Anemia (AIHA), Sickle Cell Anemia, Delayed Transfusion Reactions | Acute Hemolytic Transfusion Reactions (ABO mismatch), PNH, Microangiopathic Hemolytic Anemias (TTP, HUS, DIC), G6PD crisis, Clostridial sepsis |
| Serum Haptoglobin | Normal to moderately decreased | Severely depleted or undetectable ( < 10 mg/dL <10\text{ mg/dL} < 10 mg/dL ) (complexes with free α β \alpha\beta α β dimers and cleared by hepatic CD163) |
| Serum Hemopexin | Normal | Markedly decreased (binds free oxidized ferriheme after haptoglobin saturation) |
| Plasma Free Hemoglobin | Normal ( < 5 mg/dL <5\text{ mg/dL} < 5 mg/dL ) | Markedly elevated ( > 50 to 1 , 000 mg/dL >50\text{ to }1,000\text{ mg/dL} > 50 to 1 , 000 mg/dL ) ; pink/red plasma (hemoglobinemia) |
| Urine Hemoglobin | Negative | Positive (exceeds proximal renal tubular reabsorption; dipstick positive for heme, no intact RBCs on microscopy ) |
| Urine Hemosiderin | Negative | Positive ( Prussian blue stain on sloughed renal tubular epithelial cells 3–5 days post-event) |
| Serum Total / Unconjugated Bilirubin | Markedly elevated (indirect hyperbilirubinemia) | Mildly to moderately elevated |
| Serum Lactate Dehydrogenase (LDH) | Moderately elevated | Markedly elevated (often > 1 , 000 to 5 , 000 U/L >1,000\text{ to }5,000\text{ U/L} > 1 , 000 to 5 , 000 U/L ) |
| Characteristic Peripheral Smear | Spherocytes , microspherocytes, polychromasia | Schistocytes (helmet cells, triangular fragments) , microspherocytes |